ArticleProceedings of the National Academy of Sciences of the United States of America1998

Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.

A Faber-Elmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.